Rationale and Design of the Randomized Controlled Trial of Intensive Versus Usual ECG Screening for Atrial Fibrillation in Elderly Chinese by an Automated ECG System in Community Health Centers in Shanghai (AF-CATCH)
Design: Men and women (≥65 years) will be randomized into intensive (n=3500) and usual (n=3500) screening groups, and within the intensive screening group into intensive screening (n=2625) and more intensive screening (n=875) subgroups. ECG recordings will be performed with an automated ECG analysis system (AliveCor® heart monitor) at 1 year in the usual screening group, at 3, 6, 9, and 12 months in the intensive screening subgroup, and at 1, 2, 3, and 4 weeks and 3, 6, 9, and 12 months in the more intensive screening subgroup. The primary outcome is the detection rate of atrial fibrillation between the usual screening group and the intensive screening group. Sample size estimation was based on a projected detection rate of atrial fibrillation of 2.0% by a single ECG recording at 12 months, an improvement of 50% with more frequent ECG recordings, a=0.05, power of 80%, and a one-sided test.
Conclusions: The trial will provide evidence on the clinical effectiveness of more frequent ECG recordings by a handheld automated analysis system in the detection of atrial fibrillation.
Document Type: Research Article
Publication date: February 1, 2017
This article was made available online on May 5, 2017 as a Fast Track article with title: "Rationale and Design of the Randomized Controlled Trial of Intensive Versus Usual ECG Screening for Atrial Fibrillation in Elderly Chinese by an Automated ECG System in Community Health Centers in Shanghai (AF-CATCH)".
Cardiovascular Innovations and Applications (CVIA) publishes focused articles and original clinical research that explore novel developments in cardiovascular disease, effective control and rehabilitation in cardiovascular disease, and promote cardiovascular innovations and applications for the betterment of public health globally. The journal publishes basic research that has clinical applicability in order to promote timely communication of the latest insights relating to coronary artery disease, heart failure, hypertension, cardiac arrhythmia, prevention of cardiovascular disease with a heavy emphasis on risk factor modification. Cardiovascular Innovations and Applications is the official journal of the Great Wall International Congress of Cardiology (GW-ICC). It aims to continue the work of the GW-ICC by providing a global scientific communication platform for cardiologists that bridges East and West.
- Editorial Board
- Information for Authors
- Submit a Paper
- Subscribe to this Title
- Membership Information
- Information for Advertisers
- Terms & Conditions
- Ingenta Connect is not responsible for the content or availability of external websites